Logo image
Calcineurin-mediated protein dephosphorylation in brain nerve terminals regulates the release of glutamate
Journal article   Open access   Peer reviewed

Calcineurin-mediated protein dephosphorylation in brain nerve terminals regulates the release of glutamate

R A Nichols, G R Suplick and J M Brown
The Journal of biological chemistry, v 269(38), pp 23817-23823
23 Sep 1994
PMID: 7522234
url
https://doi.org/10.1016/s0021-9258(17)31588-0View
Published, Version of Record (VoR)CC BY V4.0 Open
url
https://doi.org/10.1016/S0021-9258(17)31588-0View
Published, Version of Record (VoR) Open

Abstract

4-Aminopyridine - pharmacology Amino Acid Sequence Animals Calcineurin Calcium - metabolism Calmodulin-Binding Proteins - pharmacology Cell-Free System Cerebral Cortex - metabolism Cyclosporine - pharmacology Dynamins Ethers, Cyclic - pharmacology Glutamates - metabolism GTP Phosphohydrolases - metabolism Membrane Potentials Molecular Sequence Data Nerve Endings - metabolism Nerve Tissue Proteins - metabolism Okadaic Acid Phosphoprotein Phosphatases - metabolism Phosphoprotein Phosphatases - pharmacology Phosphoproteins - metabolism Potassium - pharmacology Potassium Channels - drug effects Rats Synaptic Transmission - drug effects Synaptosomes - metabolism Tacrolimus - analogs & derivatives Tacrolimus - antagonists & inhibitors
In response to Ca2+ entry, several prominent brain nerve terminal phosphoproteins undergo dephosphorylation, but the relation between dephosphorylation and neurotransmitter release is unknown. Using the immunosuppressants cyclosporin A (CsA) and L-683,590 (FK-520) to inhibit specifically the Ca2+/calmodulin-dependent protein phosphatase calcineurin, we demonstrate here that Ca(2+)-dependent dephosphorylation in isolated rat brain nerve terminals (synaptosomes) is mediated by calcineurin. Pretreatment with micromolar CsA resulted in a 76-95% inhibition of stimulation-induced decreases in 32P-labeled dynamin (previously referred to as dephosphin), a phosphoprotein of M(r) = 145,000 (145-kDa protein), and a phosphoprotein of M(r) = 170,000 (170-kDa protein). Pretreatment with FK-520 also inhibited Ca(2+)-dependent dephosphorylation. Using hypotonic lysates of 32P-labeled synaptosomes, the addition of Ca2+ plus calmodulin, but not either agent alone, induced dynamin dephosphorylation. CsA and FK-520 had little to no effect on the release of glutamate induced by either K(+)-depolarization or the Ca2+ ionophore ionomycin. In contrast, calcineurin inhibition led to a substantial enhancement of glutamate release evoked by the K(+)-channel blocker 4-aminopyridine, an agent whose action most closely mimics physiological stimulation. Calcineurin inhibition had no effect on stimulation-induced changes in synaptosomal Ca2+ levels. Based on our findings, we hypothesize that Ca(2+)-dependent protein dephosphorylation resulting from calcineurin activation during physiological stimulation limits neurotransmitter release from brain nerve terminals, perhaps being dependent upon cyclic repolarization of the membrane during stimulation.

Metrics

10 Record Views
125 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Web of Science research areas
Biochemistry & Molecular Biology
Logo image